You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 9, 2025

Peru Drug Patents


✉ Email this page to a colleague

« Back to Dashboard


Drug Patents in Peru and US Equivalents

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
Patent Number Estimated Expiration Equivalent US Patent US Expiry Date Generic Name US Applicant US Tradename
74799 ⤷  Try for Free 6294540 2018-11-14 abacavir sulfate Viiv Hlthcare ZIAGEN
78799 ⤷  Try for Free 6294540 2018-11-14 abacavir sulfate Viiv Hlthcare ZIAGEN
02712000 ⤷  Try for Free 6641843 2019-08-04 abacavir sulfate Viiv Hlthcare ZIAGEN
74799 ⤷  Try for Free 6294540 2018-11-14 abacavir sulfate; lamivudine Viiv Hlthcare EPZICOM
78799 ⤷  Try for Free 6294540 2018-11-14 abacavir sulfate; lamivudine Viiv Hlthcare EPZICOM
>Patent Number >Estimated Expiration >Equivalent US Patent >US Expiry Date >Generic Name >US Applicant >US Tradename

Patentability, Enforceability, and Scope of Claims for Biopharmaceutical Patents in Peru

Introduction

When navigating the complex landscape of biopharmaceutical patents in Peru, it is crucial to understand the specific regulations, exceptions, and requirements that govern patentability, enforceability, and the scope of claims. Here are the key insights to guide you through this process.

Patentability Criteria in Peru

General Patentability

In Peru, patentability is governed by the provisions of the Legislative Decree 1075 and the Decision 486 of the Andean Community. Patents are granted for inventions that are novel, involve an inventive step, and are industrially applicable[3].

Exclusions from Patentability

Certain categories are excluded from patentability:

  • Plants, animals, and essentially biological processes for the production of plants or animals, other than non-biological or microbiological processes.
  • Diagnostic, therapeutic, and surgical methods for the treatment of humans or animals.
  • Living matter and substances that are pre-existing in nature[3].

Biopharmaceutical Inventions

Biopharmaceutical inventions, including transgenic plants and animals, are subject to these exclusions. However, non-biological or microbiological processes can be patented, providing a pathway for some biotechnological innovations[3].

Filing and Prosecution of Biopharmaceutical Patents

Language and Documentation

Patent applications must be filed in Spanish. A certified copy of the priority document and its Spanish translation must be submitted within 16 months from the priority date. A simply signed Power of Attorney must be submitted within two months from the filing date, with the option to extend this period by another two months[5].

Substantive Examination

The request for substantive examination must be filed within six months from the publication of the application. This step is crucial for determining the patentability of the invention[5].

Novelty Grace Period

Peru allows a novelty grace period of one year prior to the date of priority if the invention was disclosed by the inventor or the inventor's assignee, national office, or a third party who obtained the information directly or indirectly from the inventor or its assignee[5].

Enforceability of Biopharmaceutical Patents

Exclusive Rights

Patent holders in Peru have exclusive rights to prevent third parties from making, using, selling, offering for sale, or importing the patented invention without their consent. However, there are specific exceptions and limitations to these rights[3].

Exceptions and Limitations

  • Experimental Use: Third parties may use the patented invention for experimental purposes or scientific research without infringing the patent rights[3].
  • Regulatory Approval: Any product produced for the purpose of generating information necessary to support an application for approval for commercialization of a pharmaceutical or agrochemical product may be used, but only after the patent term has expired or for export purposes related to regulatory approval[3].
  • Compulsory Licenses: The law provides for compulsory licenses and government use under certain conditions, such as public health, national security, or public non-commercial use[3].

Protection of Data

Peru's laws do not provide robust protection for data generated in support of marketing authorization for biopharmaceuticals, which is a critical issue for biotechnology companies. This lack of protection can hinder the development and commercialization of biotechnology products[4].

Scope of Claims

Claim Requirements

Claims must be clear and concise, and they must be supported by the description. The scope of claims should be carefully drafted to ensure they are not overly broad or vague, which could lead to rejection or invalidation[5].

Utility Models

In addition to patents, inventions can also be protected as utility models in Peru. Utility models have a maximum protection period of ten years from the date of filing and are subject to formal and substantive examination[5].

Special Provisions and Requirements

Deposit of Microorganisms

For biopharmaceutical patents involving microorganisms, deposits must be made with an international depositary authority under the Budapest Treaty. This is essential for the patent procedure before the National Institute for the Defense of Competition and Intellectual Property Protection (INDECOPI)[1].

Translation and Documentation

Translation of the international application must be furnished in two copies if the application is not in Spanish. Additionally, a nucleotide and/or amino acid sequence listing in electronic form must be provided where applicable[1].

Agent Representation

Foreign patent applicants must use an agent resident in Peru, preferably a registered Peruvian patent attorney, to facilitate the registration process[5].

Maintenance and Validity

Patent Maintenance Fees

Patent maintenance fees must be paid annually in advance, starting from the first year counting from the filing date. Late payment is possible within a six-month grace period with a corresponding surcharge[5].

Validity Term

The validity term of a patent in Peru is twenty years from the date of filing[5].

Key Takeaways

  • Patentability: Biopharmaceutical inventions are subject to specific exclusions, but non-biological or microbiological processes can be patented.
  • Filing and Prosecution: Applications must be in Spanish, with specific deadlines for submitting priority documents and requesting substantive examination.
  • Enforceability: Patent holders have exclusive rights, but there are exceptions for experimental use, regulatory approval, and compulsory licenses.
  • Scope of Claims: Claims must be clear and supported by the description, with the option to protect inventions as utility models.
  • Special Provisions: Deposits of microorganisms must comply with the Budapest Treaty, and foreign applicants must use a local agent.
  • Maintenance and Validity: Annual maintenance fees are required, and the patent validity term is twenty years from the filing date.

FAQs

What are the exclusions from patentability in Peru?

In Peru, exclusions include plants, animals, and essentially biological processes, as well as diagnostic, therapeutic, and surgical methods for humans or animals[3].

Can biopharmaceutical inventions involving microorganisms be patented in Peru?

Yes, but they must comply with the Budapest Treaty for the deposit of microorganisms, and only non-biological or microbiological processes are patentable[1][3].

What is the novelty grace period in Peru?

The novelty grace period in Peru is one year prior to the date of priority if the invention was disclosed by the inventor or the inventor's assignee under specific conditions[5].

How long is the validity term of a patent in Peru?

The validity term of a patent in Peru is twenty years from the date of filing[5].

Are there any special requirements for foreign patent applicants in Peru?

Yes, foreign applicants must use an agent resident in Peru, preferably a registered Peruvian patent attorney, to facilitate the registration process[5].

Sources

  1. PCT Applicant's Guide Peru - WIPO
  2. Law guaranteeing access to and use of generic drugs in Peru - Baker & McKenzie
  3. Questionnaire on exceptions and limitations to patent rights - Peru - WIPO
  4. BIO 2011 Special 301 Submission - Regulations.gov
  5. Patent registration in Peru – IP Guide - IP-Coster

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.